Assertio to Participate in the 2023 Winter Wonderland Best Ideas Conference

Assertio Holdings, Inc. (NASDAQ: ASRT), a specialty pharmaceutical company, announced investor meetings scheduled for February 23, 2023, as part of the virtual Third Annual Winter Wonderland Best Ideas Investor Conference.

Rhea-AI Summary

Assertio Holdings, Inc. (NASDAQ: ASRT), a specialty pharmaceutical company, announced investor meetings scheduled for February 23, 2023, as part of the virtual Third Annual Winter Wonderland Best Ideas Investor Conference. CEO Dan Peisert and CFO Paul Schwichtenberg will host these meetings. Additionally, a group presentation will take place on February 22, 2023, at 9:30 AM ET, accessible via the Investor Relations section on Assertio’s website. For one-on-one meeting scheduling, interested parties can contact the conference hosts via provided email addresses.

Assertio focuses on differentiated pharmaceutical products in neurology, hospital, and pain/inflammation sectors.

Argus Session date unavailable

+0.78% session move Open Argus

Details

News Market Reaction – ASRT

The recorded move for ASRT in the trading session of this news was +0.78%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LAKE FOREST, Ill., Feb. 16, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert, CEO, and Paul Schwichtenberg, CFO, will host investor meetings Thursday, February 23, 2023 as part of the virtual Third Annual Winter Wonderland Best Ideas Investor Conference.

As part of the conference event, management will host a webcast group presentation on Wednesday, February 22, 2023 at 9:30 am Eastern Time. The webcast will be available on the Investor Relations section of the Assertio website, located at www.assertiotx.com.

For more information about scheduling a one-on-one meeting with management, please contact the conference hosts via email at angie.wright@issuerdirect.com, or Matt Kreps, Investor Relations for Assertio Holdings, at mkreps@darrowir.com.

About Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. To learn more visit www.assertiotx.com.

Investor Contact:

Matt Kreps
Managing Director
Darrow Associates
Austin, TX 
M: 214-597-8200
mkreps@darrowir.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What investor event is Assertio Holdings participating in on February 23, 2023?

Assertio Holdings will participate in the virtual Third Annual Winter Wonderland Best Ideas Investor Conference on February 23, 2023.

When will Assertio Holdings present at the investor conference?

Assertio Holdings will present on February 22, 2023, at 9:30 AM ET during the conference.

Who will represent Assertio Holdings in the investor meetings?

Dan Peisert, CEO, and Paul Schwichtenberg, CFO, will represent Assertio Holdings in the investor meetings.

How can investors access Assertio's conference presentation?

Investors can access the presentation through the Investor Relations section on Assertio's website.

What are the main therapeutic areas of Assertio Holdings?

Assertio Holdings focuses on neurology, hospital, and pain/inflammation therapeutic areas.